Rowan Hardy

1 - 10 out of 40Page size: 10

Publications

  1. 2021
  2. Accepted/In press

    Global deletion of 11β-HSD1 prevents muscle wasting associated with glucocorticoid therapy in polyarthritis

    Michael Sagmeister, , Alex Seabright, Yu-Chiang Lai, Simon Jones, Andrew Filer, , Gareth Lavery, Karim Raza, & Rowan Hardy, 15 Jul 2021, (Accepted/In press) In: International Journal of Molecular Sciences.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids

    Adam Croft, Joana Campos, Amy Naylor, Angela Taylor, Myriam Chimen, , Gareth Lavery, Karim Raza & Rowan Hardy, Feb 2021, In: Annals of the Rheumatic Diseases. 80, 2, p. 250-260 11 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in Idiopathic intracranial hypertension

    Rowan Hardy, Hannah Botfield, , , Zerin Alimajstorovic, , Michael Sagmeister, , , Andreas Yiangou, Karl-Heinz Storbeck, Angela Taylor, Lorna Gilligan, Wiebke Arlt, Paul Stewart, Jeremy Tomlinson, , Gareth Lavery & Alex Sinclair, 1 Jan 2021, In: Journal of Clinical Endocrinology and Metabolism. 106, 1, p. 174-187 14 p.

    Research output: Contribution to journal › Review article › peer-review

  5. 2020
  6. Published

    Inflammation and skeletal muscle wasting during cachexia

    Rowan Hardy & , 19 Nov 2020, In: Frontiers in Physiology. 2020, 597675.

    Research output: Contribution to journal › Review article › peer-review

  7. Published

    Therapeutic glucocorticoids mechanisms of actions in rheumatic diseases

    Karim Raza, Rowan Hardy & , Mar 2020, In: Nature Reviews Rheumatology. 16, 3, p. 133-144 12 p.

    Research output: Contribution to journal › Review article › peer-review

  8. 2019
  9. Published

    Exploring the interface between inflammatory and therapeutic glucocorticoid induced bone and muscle loss

    Rowan Hardy, 16 Nov 2019, In: International Journal of Molecular Sciences. 20, 22, 22 p., 5768.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    11β-HSD1 Plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy

    Craig Doig, , Amy Naylor, , , , Christopher Buckley, , Gareth Lavery, Karim Raza & Rowan Hardy, 16 Aug 2019, In: Arthritis Research & Therapy. 21, 1, 188.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis

    Rebecca Jones, Alex Seabright, , Yu-Chiang Lai, , Simon Jones, , Gareth Lavery, , Karim Raza & Rowan Hardy, 1 Aug 2019, In: Arthritis Research & Therapy. 21, 1, 182.

    Research output: Contribution to journal › Article › peer-review

  12. Published

    Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study

    Michael Sagmeister, Angela Taylor, , Nadya Wall, Dimitri Chanouzas, , , Wiebke Arlt, , Rowan Hardy & , Jan 2019, In: Clinical Endocrinology. 90, 1, p. 241-249 9 p.

    Research output: Contribution to journal › Article › peer-review

  13. 2018
  14. Published

    Unravelling how glucocorticoids work in rheumatoid arthritis

    Rowan Hardy & , 4 Sep 2018, In: Nature Reviews Rheumatology. p. 1759-4804 2 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 Next